For the year ending 2025-12-31, GERN had -$1,436K decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -83,500 |
| Depreciation and amortization | 474 |
| Accretion and amortization on investments, net | 6,921 |
| Amortization of debt issuance costs/debt discount | 1,071 |
| Non-cash interest expense on liabilities for sales of future royalties | 18,948 |
| Loss of extinguishment of debt | 0 |
| Stock-based compensation for services by non-employees | 88 |
| Stock-based compensation for employees and directors | 26,659 |
| Amortization of right-of-use assets | 730 |
| Increase in allowance for doubtful accounts | -50 |
| Inventory | 77,922 |
| Accounts receivable, net | 991 |
| Interest and other receivables | -614 |
| Prepaid expenses and other assets | -443 |
| Deposit and other assets | 1,865 |
| Accounts payable | 2,661 |
| Accrued compensation and benefits | 7,689 |
| Royalty financing obligation | 14,159 |
| Accrued liabilities | 15,790 |
| Operating lease liabilities | -796 |
| Net cash used in operating activities | -111,037 |
| Purchases of property and equipment | 49 |
| Purchases of marketable securities | 304,421 |
| Proceeds from maturities and sales of marketable securities | 411,717 |
| Net cash provided by (used in) investing activities | 107,247 |
| Proceeds from issuances of common stock from equity plans | 2,267 |
| Proceeds from issuance of common stock and warrants in public offering, net of paid issuance costs | 0 |
| Proceeds from exercise of warrants | 0 |
| Proceeds from sale of future royalties | 0 |
| Proceeds from debt financing, net of paid debt issuance costs and debt discounts | 0 |
| Repayment of debt | 0 |
| Net cash provided by financing activities | 2,267 |
| Net effect of exchange rates on cash, cash equivalents and restricted cash | 87 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | -1,436 |
| Cash, cash equivalents and restricted cash at the beginning of the period | 80,876 |
| Cash, cash equivalents and restricted cash at the end of the period | 79,440 |
GERON CORP (GERN)
GERON CORP (GERN)